Target intelligence / Profile preview

Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD)

Target
PISD
Molecular classification
Enzyme, Mitochondrial protein, Serine protease (by autoendoproteolytic maturation mechanism)
01

Overview

Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD) is an essential enzyme localized mainly to the inner mitochondrial membrane in eukaryotic cells. It catalyzes the decarboxylation of phosphatidylserine to phosphatidylethanolamine, a crucial step in the biosynthesis of major membrane phospholipids. PISD is initially synthesized as a proenzyme that undergoes autoendoproteolytic cleavage, generating active alpha and beta subunits; this process and subsequent enzyme activity depend on conserved catalytic residues forming a classic serine protease triad. The function of PISD is vital for the maintenance of mitochondrial structure and integrity, as well as for inter-organelle phospholipid trafficking and potentially, lipid droplet biogenesis. Genetic deficiency or pharmacological inhibition of this enzyme leads to profound mitochondrial dysfunction and can be lethal in model organisms. Because of its central metabolic role and regulatory mechanisms, PISD is under investigation as a target for antimicrobial and anticancer therapy, although safety concerns due to its essential nature must be addressed.

Other names
Phosphatidylserine decarboxylase beta chainPhosphatidylserine decarboxylase alpha chainPSDPSDCPSSCdJ858B16.2LIBFDJ858B16Phosphatidylserine decarboxylase proenzyme, mitochondrial
02

Mechanism of action

Enzyme inhibitors (disrupt maturation of the proenzyme or decarboxylase reaction to block enzymatic activity) - Lipid analogs (competing substrates or inhibitors interacting with the active site; disrupting PS binding)

03

Biological functions

Phospholipid metabolism (conversion of phosphatidylserine to phosphatidylethanolamine)Mitochondrial membrane biogenesis and functionLipid droplet biogenesis (possible)Inter-organelle lipid trafficking
04

Disease associations

Mitochondrial dysfunction (loss or mutation leads to mitochondrial defects in cell/animal models)Cancer (emergent target in anticancer therapies due to its essential role and inhibition potential)Neurodegenerative and metabolic diseases (inferred from centrality in phospholipid metabolism and mitochondrial function)Other (general cellular and developmental disorders when disrupted)
05

Safety considerations

Target essential for mitochondrial function in most eukaryotes—systemic inhibition can cause severe mitochondrial dysfunction and related toxicities (e.g., neurotoxicity, myopathy, multi-organ failure)Potential on-target effects limit therapeutic window outside of narrow or local applications
06

Interacting drugs

No approved or clinically used drugs directly targeting PISD as of current knowledge; experimental inhibitors identified for research (primarily as chemical probes or lead compounds)
07

Biomarkers

No specific clinical biomarkers established for patient selection or monitoring PISD-modulating therapy as of current knowledge; mitochondrial phosphatidylethanolamine levels and phosphatidylserine/phosphatidylethanolamine ratios may function as mechanistic biomarkers in research settings

Beyond the preview

Go deeper on Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call